Iron overload and iron chelating agent exposure in anemia-associated outer retinal degeneration: a case report and review of the literature.

The available evidence indicates that retinal degeneration in chronic anemia patients treated by deferoxamine is cause by insufficient iron chelation, not by deferoxamine. The actual role of iron chelating agents may be to promote a long enough survival to allow the slow development of retinal siderosis.